361 related articles for article (PubMed ID: 19190326)
61. Molecular mechanism of miR-153 inhibiting migration, invasion and epithelial-mesenchymal transition of breast cancer by regulating transforming growth factor beta (TGF-β) signaling pathway.
Wang J; Liang S; Duan X
J Cell Biochem; 2019 Jun; 120(6):9539-9546. PubMed ID: 30525231
[TBL] [Abstract][Full Text] [Related]
62. Unraveling the enigmatic complexities of BRMS1-mediated metastasis suppression.
Hurst DR; Welch DR
FEBS Lett; 2011 Oct; 585(20):3185-90. PubMed ID: 21827753
[TBL] [Abstract][Full Text] [Related]
63. miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro.
Lv XB; Jiao Y; Qing Y; Hu H; Cui X; Lin T; Song E; Yu F
Chin J Cancer; 2011 Dec; 30(12):821-30. PubMed ID: 22085528
[TBL] [Abstract][Full Text] [Related]
64. miR-490-3p inhibits the growth and invasiveness in triple-negative breast cancer by repressing the expression of TNKS2.
Jia Z; Liu Y; Gao Q; Han Y; Zhang G; Xu S; Cheng K; Zou W
Gene; 2016 Nov; 593(1):41-47. PubMed ID: 27506313
[TBL] [Abstract][Full Text] [Related]
65. MicroRNA-335 suppresses the proliferation, migration, and invasion of breast cancer cells by targeting EphA4.
Dong Y; Liu Y; Jiang A; Li R; Yin M; Wang Y
Mol Cell Biochem; 2018 Feb; 439(1-2):95-104. PubMed ID: 28795314
[TBL] [Abstract][Full Text] [Related]
66. MiR-155 promotes the proliferation and migration of breast cancer cells via targeting SOCS1 and MMP16.
Zhang W; Chen CJ; Guo GL
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7323-7332. PubMed ID: 30468477
[TBL] [Abstract][Full Text] [Related]
67. BRMS1 inhibits expression of NF-kappaB subunit p65, uPA and OPN in ovarian cancer cells.
Sheng XJ; Zhou DM; Liu Q; Lou SY; Song QY; Zhou YQ
Eur J Gynaecol Oncol; 2014; 35(3):236-42. PubMed ID: 24984534
[TBL] [Abstract][Full Text] [Related]
68. Over expressing miR-19b-1 suppress breast cancer growth by inhibiting tumor microenvironment induced angiogenesis.
Yin R; Guo L; Gu J; Li C; Zhang W
Int J Biochem Cell Biol; 2018 Apr; 97():43-51. PubMed ID: 29425833
[TBL] [Abstract][Full Text] [Related]
69. Regulation of UHRF1 by miR-146a/b modulates gastric cancer invasion and metastasis.
Zhou L; Zhao X; Han Y; Lu Y; Shang Y; Liu C; Li T; Jin Z; Fan D; Wu K
FASEB J; 2013 Dec; 27(12):4929-39. PubMed ID: 23982143
[TBL] [Abstract][Full Text] [Related]
70. miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.
Zhao H; Wilkie T; Deol Y; Sneh A; Ganju A; Basree M; Nasser MW; Ganju RK
Mol Cancer; 2015 Jan; 14():11. PubMed ID: 25622979
[TBL] [Abstract][Full Text] [Related]
71. Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1).
Samant RS; Debies MT; Hurst DR; Moore BP; Shevde LA; Welch DR
Cancer Lett; 2006 Apr; 235(2):260-5. PubMed ID: 15978719
[TBL] [Abstract][Full Text] [Related]
72. miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1.
Li H; Bian C; Liao L; Li J; Zhao RC
Breast Cancer Res Treat; 2011 Apr; 126(3):565-75. PubMed ID: 20505989
[TBL] [Abstract][Full Text] [Related]
73. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
74. Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1.
Shevde LA; Samant RS; Goldberg SF; Sikaneta T; Alessandrini A; Donahue HJ; Mauger DT; Welch DR
Exp Cell Res; 2002 Feb; 273(2):229-39. PubMed ID: 11822878
[TBL] [Abstract][Full Text] [Related]
75. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
[TBL] [Abstract][Full Text] [Related]
76. Progesterone receptor A promotes invasiveness and metastasis of luminal breast cancer by suppressing regulation of critical microRNAs by estrogen.
McFall T; McKnight B; Rosati R; Kim S; Huang Y; Viola-Villegas N; Ratnam M
J Biol Chem; 2018 Jan; 293(4):1163-1177. PubMed ID: 29162724
[TBL] [Abstract][Full Text] [Related]
77. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer.
Piperigkou Z; Franchi M; Götte M; Karamanos NK
Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712
[TBL] [Abstract][Full Text] [Related]
78. BRMS1 expression alters the ultrastructural, biomechanical and biochemical properties of MDA-MB-435 human breast carcinoma cells: an AFM and Raman microspectroscopy study.
Wu Y; McEwen GD; Harihar S; Baker SM; DeWald DB; Zhou A
Cancer Lett; 2010 Jul; 293(1):82-91. PubMed ID: 20083343
[TBL] [Abstract][Full Text] [Related]
79. Breast cancer metastatic potential: correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells.
Kapoor P; Saunders MM; Li Z; Zhou Z; Sheaffer N; Kunze EL; Samant RS; Welch DR; Donahue HJ
Int J Cancer; 2004 Sep; 111(5):693-7. PubMed ID: 15252837
[TBL] [Abstract][Full Text] [Related]
80. Nuclear factor-{kappa}B contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a.
Pacifico F; Crescenzi E; Mellone S; Iannetti A; Porrino N; Liguoro D; Moscato F; Grieco M; Formisano S; Leonardi A
J Clin Endocrinol Metab; 2010 Mar; 95(3):1421-30. PubMed ID: 20061417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
